Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Asthma - management

  • Mometasone/indacaterol (MF/IND) and mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) and FLU/SAL+tiotropium (TIO) in patients with inadequately controlled asthma: data from the PLATINUM program
    Richard Van Zyl-Smit, Kenneth Chapman, Huib Kerstjens, Christian Gessner, Hironori Sagara, Ana-Maria Tanase, Motoi Hosoe, Xu Shu, Abhijit Pethe, David Lawrence, Hanns-Christian Tillmann, Karen Mezzi, Peter D’Andrea
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3385; DOI: 10.1183/13993003.congress-2021.PA3385
  • Evaluation of Asthma control and oral corticosteroids in Severe Asthma
    Claudio Micheletto, Maria Beatrice Bilò, Leonardo Antonicelli, Fausto De Michele, Antonino Musarra, Adriano Vagni
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3529; DOI: 10.1183/13993003.congress-2021.PA3529
  • Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study
    Konstantinos Kostikas, Huib A. M. Kerstjens, Jorge F. Maspero, Kenneth R. Chapman, Richard N. Van Zyl-Smit, Motoi Hosoe, Ana-Maria Tanase, Abhijit Pethe, Ioannis Kottakis, Peter D'Andrea
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3392; DOI: 10.1183/13993003.congress-2021.PA3392
  • Efficacy of different dosing regimens of azithromycin in a real-world severe asthma cohort
    Ayesha Kumar, Seher Zaidi, Nicola Fay, Thomas Fitzmaurice, Abigail Watkin, Hannah Joplin, Hassan Burhan
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3526; DOI: 10.1183/13993003.congress-2021.PA3526
  • Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
    Aniek Markus, Peter Rijnbeek, Jan Kors, Guy Brusselle, Edward Burn, Daniel Prieto-Alhambra, Katia Verhamme
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3520; DOI: 10.1183/13993003.congress-2021.PA3520
  • Exploring the psychological impact of the COVID-19 pandemic on adults with asthma: A quantitative study
    Kirstie McClatchey, Tracy Jackson, Emma Kinley, Amy Chan, Noelle Morgan, Jessica Rees, Hilary Pinnock
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3562; DOI: 10.1183/13993003.congress-2021.PA3562
  • Healthcare costs associated with short-acting ß2-agonist use in asthma: an observational UK study from the SABINA global programme
    Darush Attar, Toby Capstick, Deborah Leese, Sofie Arnetorp, Eleni Rapsomaniki, Keith Peres Da Costa, Yang Xu, Jennifer K Quint
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3525; DOI: 10.1183/13993003.congress-2021.PA3525
  • Community pharmacist counseling improves adherence and asthma control: a nationwide observational study
    Barbara Putman, Anna Vanoverschelde, Els Mehuys, Louise Coucke, Lies Lahousse
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3394; DOI: 10.1183/13993003.congress-2021.PA3394
  • SABA use increase weeks before asthma exacerbations recorded via a digital inhaler
    Mark Levy, Guilherme Safioti, Michael Reich, Randall Brown, Michael Depietro
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3397; DOI: 10.1183/13993003.congress-2021.PA3397
  • Efficiency of a Nebulizer Filter Kit to Prevent Environmental Contamination During Nebulizer Therapy
    Mark Nagel, Nathaniel Hoffman, Jason Suggett
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3401; DOI: 10.1183/13993003.congress-2021.PA3401

Pages

  • Previous
  • Next
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 220
  • Acute lung injury and critical care (82)
  • Asthma and allergy (662)
  • CF and non-CF bronchiectasis (278)
  • COPD and smoking (909)
  • Epidemiology, occupational and environmental lung disease (214)
  • Genetics (60)
  • Interstitial and orphan lung disease (499)
  • Lung biology and experimental studies (318)
  • Lung cancer (282)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (394)
  • Pulmonary pharmacology and therapeutics (141)
  • Pulmonary vascular disease (523)
  • Respiratory clinical practice (171)
  • Respiratory infections and tuberculosis (973)
  • Sleep medicine (267)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • ERS clinical practice guidelines on treatment of sarcoidosis
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society